| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Cells | 14 | 2024 | 426 | 3.120 |
Why?
|
| Intestinal Mucosa | 10 | 2024 | 131 | 2.840 |
Why?
|
| Peyer's Patches | 10 | 2017 | 16 | 2.440 |
Why?
|
| Mucous Membrane | 6 | 2020 | 34 | 2.290 |
Why?
|
| Immunity, Mucosal | 6 | 2024 | 52 | 2.200 |
Why?
|
| Staphylococcus aureus | 4 | 2020 | 91 | 1.580 |
Why?
|
| Vaccines | 5 | 2015 | 64 | 1.530 |
Why?
|
| Dust | 2 | 2022 | 55 | 1.420 |
Why?
|
| Lymphoid Tissue | 5 | 2024 | 19 | 1.360 |
Why?
|
| Mice | 34 | 2024 | 6490 | 1.270 |
Why?
|
| Pneumonia | 2 | 2022 | 60 | 1.260 |
Why?
|
| Lung | 2 | 2023 | 484 | 1.230 |
Why?
|
| Staphylococcal Infections | 2 | 2020 | 65 | 1.230 |
Why?
|
| Membrane Proteins | 6 | 2012 | 548 | 1.110 |
Why?
|
| Flagellin | 2 | 2019 | 18 | 1.090 |
Why?
|
| Drug Delivery Systems | 4 | 2012 | 273 | 1.090 |
Why?
|
| Animals | 44 | 2024 | 16695 | 1.070 |
Why?
|
| Immunologic Surveillance | 3 | 2019 | 7 | 0.980 |
Why?
|
| Colitis | 2 | 2017 | 69 | 0.970 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 580 | 0.920 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2017 | 5 | 0.860 |
Why?
|
| Epithelium | 4 | 2019 | 78 | 0.800 |
Why?
|
| Ileitis | 1 | 2022 | 2 | 0.770 |
Why?
|
| Inflammation | 4 | 2021 | 729 | 0.750 |
Why?
|
| Immunity, Innate | 3 | 2022 | 168 | 0.740 |
Why?
|
| Adhesins, Bacterial | 2 | 2020 | 20 | 0.730 |
Why?
|
| Crohn Disease | 1 | 2022 | 69 | 0.720 |
Why?
|
| Carrier Proteins | 4 | 2011 | 318 | 0.710 |
Why?
|
| Allergens | 2 | 2021 | 64 | 0.710 |
Why?
|
| Microvilli | 3 | 2016 | 9 | 0.640 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2009 | 38 | 0.620 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 40 | 0.610 |
Why?
|
| Flagella | 1 | 2019 | 31 | 0.610 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 40 | 0.590 |
Why?
|
| Bacterial Vaccines | 1 | 2019 | 129 | 0.570 |
Why?
|
| Brain Stem | 1 | 2018 | 51 | 0.550 |
Why?
|
| Nanoparticles | 5 | 2020 | 449 | 0.540 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 12 | 0.540 |
Why?
|
| Peptides | 2 | 2012 | 357 | 0.530 |
Why?
|
| Fungi | 1 | 2018 | 103 | 0.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 100 | 0.510 |
Why?
|
| Static Electricity | 2 | 2014 | 85 | 0.510 |
Why?
|
| Lactic Acid | 4 | 2023 | 110 | 0.510 |
Why?
|
| Cell Differentiation | 9 | 2024 | 633 | 0.500 |
Why?
|
| Dendritic Cells | 9 | 2019 | 130 | 0.480 |
Why?
|
| Polyglycolic Acid | 3 | 2011 | 48 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 8 | 2016 | 686 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2022 | 379 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 1804 | 0.450 |
Why?
|
| Epitopes | 1 | 2015 | 155 | 0.450 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 90 | 0.440 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 2 | 0.440 |
Why?
|
| Cell Lineage | 3 | 2015 | 104 | 0.430 |
Why?
|
| Endocytosis | 2 | 2019 | 117 | 0.430 |
Why?
|
| Administration, Intranasal | 2 | 2012 | 89 | 0.420 |
Why?
|
| Vaccination | 2 | 2012 | 332 | 0.410 |
Why?
|
| Ligands | 3 | 2016 | 387 | 0.400 |
Why?
|
| Aerosols | 2 | 2023 | 53 | 0.380 |
Why?
|
| Claudins | 1 | 2012 | 8 | 0.380 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 15 | 0.380 |
Why?
|
| Nanotechnology | 2 | 2011 | 176 | 0.370 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2010 | 276 | 0.370 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 63 | 0.370 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 80 | 0.360 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 31 | 0.360 |
Why?
|
| Particle Size | 4 | 2023 | 267 | 0.350 |
Why?
|
| Transport Vesicles | 1 | 2011 | 22 | 0.340 |
Why?
|
| Enterotoxins | 1 | 2011 | 33 | 0.340 |
Why?
|
| Humans | 21 | 2024 | 42163 | 0.340 |
Why?
|
| Signal Transduction | 4 | 2017 | 2111 | 0.330 |
Why?
|
| Poloxamer | 1 | 2010 | 13 | 0.330 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2022 | 22 | 0.330 |
Why?
|
| Ions | 1 | 2010 | 71 | 0.320 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 378 | 0.320 |
Why?
|
| Hemagglutinins | 1 | 2009 | 9 | 0.320 |
Why?
|
| Antigen-Presenting Cells | 3 | 2012 | 31 | 0.310 |
Why?
|
| Clostridium perfringens | 1 | 2008 | 4 | 0.300 |
Why?
|
| Enterobacteriaceae | 1 | 2009 | 29 | 0.300 |
Why?
|
| Endotoxins | 1 | 2008 | 18 | 0.290 |
Why?
|
| Biofilms | 2 | 2020 | 178 | 0.290 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2016 | 158 | 0.280 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 70 | 0.280 |
Why?
|
| Models, Immunological | 1 | 2008 | 21 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2008 | 181 | 0.270 |
Why?
|
| Neuroimmunomodulation | 1 | 2007 | 12 | 0.260 |
Why?
|
| Dextran Sulfate | 2 | 2017 | 17 | 0.260 |
Why?
|
| Immune System | 1 | 2007 | 40 | 0.260 |
Why?
|
| Immunity | 2 | 2020 | 60 | 0.250 |
Why?
|
| Homeostasis | 1 | 2008 | 193 | 0.250 |
Why?
|
| Up-Regulation | 1 | 2009 | 534 | 0.250 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 683 | 0.240 |
Why?
|
| Central Nervous System | 1 | 2007 | 150 | 0.240 |
Why?
|
| Colon | 2 | 2017 | 118 | 0.240 |
Why?
|
| Cell Line | 4 | 2010 | 1416 | 0.240 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 658 | 0.230 |
Why?
|
| Flow Cytometry | 4 | 2013 | 411 | 0.230 |
Why?
|
| Drug Carriers | 2 | 2020 | 169 | 0.220 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 11 | 0.220 |
Why?
|
| Caco-2 Cells | 3 | 2010 | 59 | 0.210 |
Why?
|
| Thymus Gland | 2 | 2023 | 74 | 0.210 |
Why?
|
| Self Tolerance | 1 | 2023 | 6 | 0.210 |
Why?
|
| Administration, Inhalation | 1 | 2023 | 92 | 0.210 |
Why?
|
| Mice, Knockout | 7 | 2018 | 1010 | 0.210 |
Why?
|
| Protein Binding | 3 | 2020 | 1076 | 0.200 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 151 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 1554 | 0.190 |
Why?
|
| Bacteria | 2 | 2019 | 285 | 0.190 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 183 | 0.190 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 318 | 0.180 |
Why?
|
| Cytokines | 3 | 2020 | 661 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 109 | 0.180 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1420 | 0.180 |
Why?
|
| Surface Plasmon Resonance | 3 | 2011 | 35 | 0.180 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 54 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 93 | 0.180 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 18 | 0.170 |
Why?
|
| Transcription Factor RelB | 4 | 2009 | 8 | 0.170 |
Why?
|
| Phototherapy | 1 | 2020 | 25 | 0.170 |
Why?
|
| Erythrocytes | 1 | 2020 | 126 | 0.160 |
Why?
|
| Disease Progression | 1 | 2022 | 661 | 0.160 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 51 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 293 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2020 | 124 | 0.150 |
Why?
|
| Cricetulus | 2 | 2009 | 82 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 350 | 0.150 |
Why?
|
| CHO Cells | 2 | 2009 | 123 | 0.150 |
Why?
|
| Cricetinae | 2 | 2009 | 241 | 0.150 |
Why?
|
| Disulfides | 1 | 2019 | 92 | 0.150 |
Why?
|
| DNA Primers | 3 | 2011 | 295 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2019 | 114 | 0.140 |
Why?
|
| Phenotype | 2 | 2019 | 774 | 0.140 |
Why?
|
| Protein Conformation | 1 | 2019 | 420 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 134 | 0.140 |
Why?
|
| Arginase | 1 | 2018 | 14 | 0.140 |
Why?
|
| Air Pollution | 1 | 2019 | 87 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 117 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2018 | 1617 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 101 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 44 | 0.140 |
Why?
|
| Strongylida Infections | 1 | 2018 | 27 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 13 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1265 | 0.140 |
Why?
|
| Models, Molecular | 2 | 2019 | 875 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2018 | 122 | 0.130 |
Why?
|
| Models, Animal | 2 | 2020 | 149 | 0.130 |
Why?
|
| RANK Ligand | 1 | 2017 | 19 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 128 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 226 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 415 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2018 | 165 | 0.130 |
Why?
|
| Receptors, CCR7 | 1 | 2016 | 17 | 0.130 |
Why?
|
| Citrobacter rodentium | 1 | 2016 | 1 | 0.120 |
Why?
|
| Irritants | 1 | 2016 | 8 | 0.120 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 12 | 0.120 |
Why?
|
| Biological Transport | 2 | 2009 | 201 | 0.120 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 72 | 0.120 |
Why?
|
| Salmonella enterica | 1 | 2015 | 9 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 47 | 0.120 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 87 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 183 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2598 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 72 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 253 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 235 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 115 | 0.110 |
Why?
|
| Surface Properties | 1 | 2014 | 157 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 522 | 0.100 |
Why?
|
| Gene Expression | 2 | 2009 | 692 | 0.100 |
Why?
|
| Cranial Sutures | 1 | 2012 | 2 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2013 | 57 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 133 | 0.100 |
Why?
|
| Monitoring, Immunologic | 1 | 2012 | 3 | 0.100 |
Why?
|
| Goblet Cells | 1 | 2012 | 12 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 649 | 0.090 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2012 | 15 | 0.090 |
Why?
|
| Nanocapsules | 1 | 2012 | 19 | 0.090 |
Why?
|
| Immunization | 1 | 2012 | 93 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 15 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2013 | 180 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2012 | 55 | 0.090 |
Why?
|
| Complement Activation | 1 | 2011 | 14 | 0.090 |
Why?
|
| Complement C3 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2011 | 148 | 0.090 |
Why?
|
| Models, Biological | 2 | 2012 | 711 | 0.090 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 29 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2011 | 47 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 534 | 0.090 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2010 | 9 | 0.080 |
Why?
|
| Toxoplasma | 1 | 2010 | 12 | 0.080 |
Why?
|
| Chemokine CCL21 | 1 | 2010 | 14 | 0.080 |
Why?
|
| Polymers | 1 | 2012 | 151 | 0.080 |
Why?
|
| Cell Count | 2 | 2008 | 140 | 0.080 |
Why?
|
| Nasopharynx | 1 | 2010 | 5 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 17 | 0.080 |
Why?
|
| Microglia | 2 | 2010 | 204 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 698 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 207 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2023 | 722 | 0.080 |
Why?
|
| Otitis Media | 1 | 2009 | 2 | 0.080 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 5 | 0.080 |
Why?
|
| Streptolysins | 1 | 2009 | 4 | 0.080 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 1 | 2009 | 5 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2009 | 31 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2009 | 27 | 0.080 |
Why?
|
| Chemokine CCL20 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2009 | 34 | 0.080 |
Why?
|
| Genes, Bacterial | 1 | 2009 | 92 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2009 | 68 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2009 | 12 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 83 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2009 | 59 | 0.070 |
Why?
|
| Hemagglutinins, Viral | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 84 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 94 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 160 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2009 | 154 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 295 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 223 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2009 | 268 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 221 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 301 | 0.070 |
Why?
|
| Macrophages | 2 | 2009 | 515 | 0.070 |
Why?
|
| Spleen | 3 | 2020 | 199 | 0.070 |
Why?
|
| Cross-Priming | 1 | 2006 | 1 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2006 | 43 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2003 | 59 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 138 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 255 | 0.050 |
Why?
|
| Endocrine Cells | 1 | 2023 | 1 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2003 | 31 | 0.050 |
Why?
|
| Muscle Cells | 1 | 2023 | 12 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 66 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 12 | 0.050 |
Why?
|
| Autoantigens | 1 | 2004 | 85 | 0.050 |
Why?
|
| Lactobacillus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Ghrelin | 1 | 2023 | 17 | 0.050 |
Why?
|
| Plant Lectins | 1 | 2003 | 8 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 97 | 0.050 |
Why?
|
| Dermatitis | 1 | 2003 | 10 | 0.050 |
Why?
|
| Laminin | 1 | 2003 | 58 | 0.050 |
Why?
|
| Species Specificity | 1 | 2004 | 279 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 200 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2003 | 195 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 91 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 64 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2003 | 67 | 0.050 |
Why?
|
| PrPSc Proteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 99 | 0.050 |
Why?
|
| Scrapie | 1 | 2002 | 14 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2002 | 4 | 0.050 |
Why?
|
| Chromatin | 1 | 2023 | 179 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 928 | 0.040 |
Why?
|
| Rats | 1 | 2009 | 3701 | 0.040 |
Why?
|
| Male | 2 | 2018 | 22779 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2020 | 25 | 0.040 |
Why?
|
| Infrared Rays | 1 | 2020 | 17 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 65 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1066 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2023 | 599 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 153 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 557 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2010 | 149 | 0.040 |
Why?
|
| Industrial Waste | 1 | 2019 | 16 | 0.040 |
Why?
|
| Female | 4 | 2023 | 24018 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 38 | 0.040 |
Why?
|
| Nippostrongylus | 1 | 2018 | 1 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 143 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2018 | 8 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2018 | 33 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2018 | 63 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 727 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 532 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 205 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 105 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 205 | 0.030 |
Why?
|
| Liver | 1 | 2020 | 503 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 237 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2016 | 143 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2006 | 47 | 0.030 |
Why?
|
| Chimera | 2 | 2006 | 18 | 0.030 |
Why?
|
| Cartilage | 1 | 2015 | 16 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 48 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2012 | 3 | 0.020 |
Why?
|
| Skull | 1 | 2013 | 27 | 0.020 |
Why?
|
| Cell Size | 1 | 2013 | 46 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 53 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 54 | 0.020 |
Why?
|
| Biology | 1 | 2012 | 20 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2013 | 106 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 24 | 0.020 |
Why?
|
| Pyruvate Oxidase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2009 | 2 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 49 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 244 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 183 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 491 | 0.020 |
Why?
|
| Reverse Transcription | 1 | 2009 | 23 | 0.020 |
Why?
|
| Brain | 2 | 2010 | 1452 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2009 | 119 | 0.020 |
Why?
|
| Astrocytes | 1 | 2010 | 244 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 1188 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 168 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2009 | 135 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 602 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 266 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2006 | 2 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2006 | 2 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 324 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2004 | 2 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 4 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 50 | 0.010 |
Why?
|
| Mice, Congenic | 1 | 2003 | 3 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 318 | 0.010 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2003 | 16 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2003 | 57 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 198 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2003 | 10 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2003 | 6 | 0.010 |
Why?
|
| Antigens, CD1 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 65 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 101 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 59 | 0.010 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2003 | 3 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 26 | 0.010 |
Why?
|
| Hybridomas | 1 | 2003 | 24 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2002 | 2 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2002 | 2 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 436 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 278 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 355 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1559 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 11819 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 13458 | 0.010 |
Why?
|